How Big Is the Exosome Therapeutics Market | Current Trends and Global Forecast 2025

Q: What is the future market valuation of exosome therapeutics?

The exosome therapeutics market is projected to exceed USD 470 million by 2031 with strong growth in regenerative therapies.

Q: Which diseases are driving growth in the exosome therapeutics market?

Cancer, neurodegenerative diseases, cardiovascular conditions, and autoimmune disorders are key focus areas for exosome-based treatments.

Q: What is the growth outlook for the exosome therapeutics market?

The market is in early stages but growing rapidly, supported by rising R&D investments and promising preclinical results in oncology and neurology.

Q: Who are the key players in the exosome therapeutics market?

Leading companies include Codiak BioSciences, Evox Therapeutics, Exopharm, Aegle Therapeutics, and Capricor Therapeutics—driving innovation in exosome engineering and clinical development.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6704

Publication Date: Jul 2025

How Big Is the Exosome Therapeutics Market?

According to 6Wresearch internal database and industry insights, the exosome therapeutics market was valued at USD 78 million in 2024 and is anticipated to surpass USD 470 million by 2031, growing at a CAGR of 28.6%.

This rapid growth is fueled by the increasing clinical interest in exosome-based drug delivery and regenerative medicine.

Growth Factors of the Exosome Therapeutics Market

Development of new exosome isolation and engineering methods
Increased focus on regenerative therapies for neurodegenerative disease
High exploration for non-immunogenic delivery vehicles for therapeutics
Strategic partnerships between biotech companies and research institutions
Increase in regulatory support around biologics and cell-free approaches
Increase in the number of clinical trials in oncology and cardiology

Exosome Therapeutics Market Trends

Exosome Therapeutics Market is experiencing increased investment in stem cell derived exosome drug candidates in the exosome therapeutics market. Companies are transitioning to exosome-based delivery models, especially in RNA therapies and gene editing technologies. There is increased attention on off-the-shelf exosome products in their clinical pipelines.

Emerging Developments in the Exosome Therapeutics Market

In the Exosome Therapeutics Market, new research around exosome delivery in the treatment of autoimmune and rare genetic disorders are explored. Regulatory progress is allowing for more Investigational New Drug (IND) applications specifically for exosome therapeutics. Companies are also developing large-scale manufacturing, storage, and distribution approaches for clinical applications.